PLATELET DISEASESPP 15
LONG-TERM OUTCOMES OF PATIENTS TREATED WITH CAPLACIZUMAB FOR IMMUNE-MEDIATED THROMBOTIC THROMBOCYTOPENIC PURPURA (ITTP): THE POST-HERCULES STUDY
Özgür Pektaş1, Marie Scully2, Javier de la Rubia3, Katerina Pavenski4, Ara Metjian5, Paul Knöbl6, Flora Peyvandi7, Spero Cataland8, Paul Coppo9, Johanna A. Kremer Hovinga10, Jessica Minkue Mi Edou11, Rui de Passos Sousa11, Sriya Gunawardena12, Julie Lin12,13
1 Sanofi, Istanbul, Turkey
2 Department of Haematology, University College London Hospitals, London, UK
3 Hematology Department, Internal Medicine, School of Medicine and Dentistry, Catholic University of Valencia and Hospital Doctor Peset, Valencia, Spain
4 Departments of Medicine and Laboratory Medicine, St. Michael's Hospital and University of Toronto, Toronto, ON, Canada
5 Division of Hematology, Department of Medicine, University of Colorado–Anschutz Medical Center, Denver, CO, USA
6 Department of Medicine 1, Division of Hematology and Hemostasis, Medical University of Vienna, Vienna, Austria
7 Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Angelo Bianchi Bonomi Hemophilia and Thrombosis Center and Fondazione Luigi Villa, Milan, Italy, and Università degli Studi di Milano, Department of Pathophysiology and Transplantation, Milan, Italy
8 Department of Internal Medicine, Ohio State University, Columbus, OH, USA
9 Department of Hematology, Reference Center for Thrombotic Microangiopathies (CNR-MAT), Saint-Antoine University Hospital, AP-HP, Paris, France
10 Department of Hematology and Central Hematology Laboratory, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland
11 Formerly Sanofi, Zwijnaarde, Belgium
12 Formerly Sanofi, Lisbon, Portugal
13 Sanofi, Cambridge, MA, USA
Ver másRead
1350
Timeswas read the article
614
Total PDF
736
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 17 | 10 | 27 |
| 2025 5 | 52 | 10 | 62 |
| 2025 4 | 42 | 16 | 58 |
| 2025 3 | 55 | 14 | 69 |
| 2025 2 | 43 | 26 | 69 |
| 2025 1 | 34 | 15 | 49 |
| 2024 12 | 21 | 12 | 33 |
| 2024 11 | 25 | 18 | 43 |
| 2024 10 | 33 | 21 | 54 |
| 2024 9 | 38 | 21 | 59 |
| 2024 8 | 34 | 28 | 62 |
| 2024 7 | 33 | 22 | 55 |
| 2024 6 | 34 | 20 | 54 |
| 2024 5 | 41 | 16 | 57 |
| 2024 4 | 30 | 21 | 51 |
| 2024 3 | 20 | 28 | 48 |
| 2024 2 | 17 | 35 | 52 |
| 2024 1 | 12 | 29 | 41 |
| 2023 12 | 15 | 24 | 39 |
| 2023 11 | 20 | 35 | 55 |
| 2023 10 | 8 | 20 | 28 |
| 2023 9 | 12 | 31 | 43 |
| 2023 8 | 12 | 16 | 28 |
| 2023 7 | 18 | 13 | 31 |
| 2023 6 | 17 | 15 | 32 |
| 2023 5 | 10 | 15 | 25 |
| 2023 4 | 3 | 4 | 7 |
| 2023 3 | 5 | 13 | 18 |
| 2023 2 | 6 | 12 | 18 |
| 2023 1 | 7 | 12 | 19 |
| 2022 12 | 11 | 18 | 29 |
| 2022 11 | 4 | 8 | 12 |
| 2022 10 | 7 | 16 | 23 |
Show all
